Clinical Management of Challenges in Allogeneic Stem Cell Transplant
The purpose of the book is to focus attention and offer suggestions on controversial and challenging topics in allogeneic stem cell transplant. Over 40,000 allogeneic hematopoietic cell transplants (HCT) are done worldwide each year. Despite advances in allogeneic transplant, the cure rate is only 5...
Wedi'i Gadw mewn:
| Awdur Corfforaethol: | |
|---|---|
| Awduron Eraill: | |
| Fformat: | Electronig eLyfr |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| Rhifyn: | 1st ed. 2025. |
| Cyfres: | Advances in Experimental Medicine and Biology,
1475 |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/978-3-031-84988-6 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-84988-6 | ||
| 003 | DE-He213 | ||
| 005 | 20260810162834.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 250609s2025 sz | o |||| 0|eng d | ||
| 020 | |a 9783031849886 |9 978-3-031-84988-6 | ||
| 024 | 7 | |a 10.1007/978-3-031-84988-6 |2 doi | |
| 050 | 4 | |a QH588.S83 | |
| 072 | 7 | |a PSC |2 bicssc | |
| 072 | 7 | |a SCI072000 |2 bisacsh | |
| 072 | 7 | |a PSC |2 thema | |
| 082 | 0 | 4 | |a 571.6 |2 23 |
| 082 | 0 | 4 | |a 616.02774 |2 23 |
| 245 | 1 | 0 | |a Clinical Management of Challenges in Allogeneic Stem Cell Transplant |h [electronic resource] / |c edited by Karen Ballen. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2025. | |
| 300 | |a 1 online resource (VIII, 228 p. 6 illus.). |b 5 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 1475 | |
| 505 | 0 | |a Access to Transplant Care and Social Determinants of Health -- Allogeneic Transplantation for Older Adults -- Conditioning Regimen Options -- Graft source choice -- Optimal GVHD Prophylaxis -- Modern era challenges in the clinical management of graft versus host disease -- Acute Myeloid Leukemia Use of Measurable Residual Disease to Improve Outcomes -- Clinical Management of Challenges in Allogeneic Stem Cell Transplant -- Myelofibrosis Timing of Transplantation and Management of Splenomegaly -- Hematopoietic Stem Cell Transplantation in Sickle Cell Disease -- Pharmacological Maintenance Therapies after Allogeneic Hematopoietic Cell Transplantation -- Challenges and opportunities in the care of hematopoietic cell transplant survivors in the modern era. | |
| 520 | |a The purpose of the book is to focus attention and offer suggestions on controversial and challenging topics in allogeneic stem cell transplant. Over 40,000 allogeneic hematopoietic cell transplants (HCT) are done worldwide each year. Despite advances in allogeneic transplant, the cure rate is only 50-70%, depending on disease and patient factors. The book focuses on key topics such as patient selection, donor selection, conditioning regimens, graft vs. host disease prophylaxis regimens, maintenance strategies, and other topics that affect patient outcomes. The authors also discuss access to transplant care. Through dissemination of these topics, we hope to educate health care professionals caring for these patients, and improve patient outcomes. This is an essential resource for transplant physicians, hematologists/oncologists, and advance practice providers. Several of the topics are controversial issues that are discussed “round the table” frequently by transplant teams. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Stem cells. | |
| 650 | 0 | |a Hematology. | |
| 650 | 0 | |a Transplantation of organs, tissues, etc. | |
| 650 | 0 | |a Cancer. | |
| 650 | 1 | 4 | |a Stem Cell Biology. |
| 650 | 2 | 4 | |a Hematology. |
| 650 | 2 | 4 | |a Transplantation. |
| 650 | 2 | 4 | |a Cancer Stem Cells. |
| 700 | 1 | |a Ballen, Karen. |e editor. |0 (orcid)0000-0003-1706-3975 |1 https://orcid.org/0000-0003-1706-3975 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031849879 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031849893 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031849909 |
| 830 | 0 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 1475 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-84988-6 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 912 | |a ZDB-2-236 | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 950 | |a Focus Bundle Molecular and Cellular Life Sciences (SpringerNature-85406) | ||